These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24108440)

  • 1. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
    Kraguljac NV; White DM; Reid MA; Lahti AC
    JAMA Psychiatry; 2013 Dec; 70(12):1294-302. PubMed ID: 24108440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
    Hutcheson NL; Reid MA; White DM; Kraguljac NV; Avsar KB; Bolding MS; Knowlton RC; den Hollander JA; Lahti AC
    Schizophr Res; 2012 Sep; 140(1-3):136-42. PubMed ID: 22831772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Reid MA; White DM; Kraguljac NV; Lahti AC
    Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
    Kegeles LS; Shungu DC; Anjilvel S; Chan S; Ellis SP; Xanthopoulos E; Malaspina D; Gorman JM; Mann JJ; Laruelle M; Kaufmann CA
    Psychiatry Res; 2000 May; 98(3):163-75. PubMed ID: 10821999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
    Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
    Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
    Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
    Reid MA; Kraguljac NV; Avsar KB; White DM; den Hollander JA; Lahti AC
    Schizophr Res; 2013 Jul; 147(2-3):348-54. PubMed ID: 23706412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of endurance training and table soccer on brain metabolites in schizophrenia.
    Rauchmann BS; Ghaseminejad F; Keeser D; Keller-Varady K; Schneider-Axmann T; Takahashi S; Karali T; Helms G; Dechent P; Maurus I; Hasan A; Wobrock T; Ertl-Wagner B; Schmitt A; Malchow B; Falkai P
    Brain Imaging Behav; 2020 Apr; 14(2):515-526. PubMed ID: 31686308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study.
    Klär AA; Ballmaier M; Leopold K; Häke I; Schaefer M; Brühl R; Schubert F; Gallinat J
    Neuroimage; 2010 Oct; 53(1):51-7. PubMed ID: 20541020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
    Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
    Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.
    Fayed N; Garcia-Campayo J; Magallón R; Andrés-Bergareche H; Luciano JV; Andres E; Beltrán J
    Arthritis Res Ther; 2010; 12(4):R134. PubMed ID: 20609227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery].
    Chang HM; Qi ST; Yang KJ; Wang KW; Guo ZW; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):996-8. PubMed ID: 19460730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal metabolites in asthma and their implications for cognitive function.
    Kroll JL; Steele AM; Pinkham AE; Choi C; Khan DA; Patel SV; Chen JR; Aslan S; Sherwood Brown E; Ritz T
    Neuroimage Clin; 2018; 19():213-221. PubMed ID: 30035015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
    Block W; Träber F; von Widdern O; Metten M; Schild H; Maier W; Zobel A; Jessen F
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):415-22. PubMed ID: 18845018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
    Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia.
    Kraguljac NV; White DM; Hadley J; Reid MA; Lahti AC
    Hippocampus; 2014 Dec; 24(12):1524-32. PubMed ID: 25045047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
    Bustillo JR; Chen H; Gasparovic C; Mullins P; Caprihan A; Qualls C; Apfeldorf W; Lauriello J; Posse S
    Biol Psychiatry; 2011 Jan; 69(1):19-27. PubMed ID: 20970118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment.
    Gurler D; White DM; Kraguljac NV; Ver Hoef L; Martin C; Tennant B; Lahti AC
    Neuropsychobiology; 2021; 80(1):12-24. PubMed ID: 32316023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.